These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29131265)

  • 1. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
    Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
    Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer.
    Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Sci Rep; 2017 Sep; 7(1):10939. PubMed ID: 28887549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular transformation of human mammary epithelial cells by SATB2.
    Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK
    Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y; Liu YH; Hu YY; Chen L; Li JM
    World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
    Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
    Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker.
    Yu W; Ma Y; Shankar S; Srivastava RK
    Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization.
    Seong BK; Lau J; Adderley T; Kee L; Chaukos D; Pienkowska M; Malkin D; Thorner P; Irwin MS
    Oncogene; 2015 Jul; 34(27):3582-92. PubMed ID: 25220418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
    J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
    Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
    FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
    Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
    Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
    Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
    Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin Plays an Anti-Osteosarcoma Role
    Zhao ZF; Cheng XF; Yu M; Shi WF; Zhang T
    Discov Med; 2024 Aug; 36(187):1648-1656. PubMed ID: 39190380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells.
    Li Y; Xian M; Yang B; Ying M; He Q
    Stem Cell Reports; 2017 Jun; 8(6):1617-1629. PubMed ID: 28552603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.